Paratek Pharmaceuticals and Optinose, Inc. (NASDAQ: OPTN) today announced they have entered into a definitive merger agreement under which Paratek ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE